Stock listing

Pyc Therapeutics Limited

Selected listing: PYC · ASX · AUD · AU

Pyc Therapeutics Limited (ASX:PYC), Health Technology. Latest release Sep 4, 2026: S&P DJI Announces September 2026 Quarterly Rebalance.

PYC:ASXAUDAUUpdated October 2, 2026
Pyc Therapeutics Limited logo
Ticker
ASX:PYC
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
ASX
Currency
AUD

About Pyc Therapeutics Limited

Pyc Therapeutics Limited is a public company listed on the Australian market under the ticker PYC. Pyc Therapeutics focuses on developing innovative therapeutic solutions, contributing to advancements in the healthcare sector.

Latest news from Pyc Therapeutics Limited

S&P DJI Announces September 2026 Quarterly Rebalance

September 4, 2026

PKD - Safety Committee Approves Dose Escalation

July 21, 2026

ADOA Program Update

July 20, 2026

PKD - Initiation of Multiple Dose Clinical Trial

May 6, 2026

Presentation of Ophthalmology Clinical Trial Data at ARVO

May 3, 2026

All Pyc Therapeutics Limited news →

Research Pyc Therapeutics Limited

Pyc Therapeutics Limited company profile

View the public company page for Pyc Therapeutics Limited on 6ix.

Pyc Therapeutics Limited news

Read company news and market updates connected to Pyc Therapeutics Limited.

Pyc Therapeutics Limited investor events

Find investor webinars, events, and replay context for Pyc Therapeutics Limited.

Alternate listings

PYCXF:OTC

US · USD

Alternate listing for Pyc Therapeutics Limited; the primary context on this page is PYC:ASX.